Alzheimer's disease diagnosis by detecting exogenous fluorescent signal of ligand bound to beta amyloid in the lens of human eye: An exploratory study

Frontiers in Neurology

Volumn 4 MAY, Issue , 2013, Pages

  Kerbage, Charles ^a   Sadowsky, Carl H ^b   Jennings, Danna ^c   Cagle, Gerald D ^a   Hartung, Paul D ^a  

^a Cognoptix Inc ^*  (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c Molecular NeuroImaging LLC   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; Biomarker; Diagnosis; Human eyes

Indexed keywords

AMYLOID BETA PROTEIN; DEXMEDETOMIDINE; FLUORESCENT DYE; KETAMINE;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EXPLORATORY RESEARCH; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LASER MICROSCOPY; LENS; LIGAND BINDING; MALE; MINI MENTAL STATE EXAMINATION; NONHUMAN; PROTEIN BINDING; QUANTITATIVE ANALYSIS; SUPRAOPTIC NUCLEUS; VISUAL ACUITY;

EID: 84878796826     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00062     Document Type: Article

References (27)

1. Alzheimer's Association. (2011). Alzheimer's disease facts and figures. Alzheimers Dement. 7, 2.
2. Brookmeyer, R., Evans, D. A., Hebert, L., Langa, K. M., Heeringa, S. G., Plassman, B. L., et al. (2011). National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 7, 61-73. doi:10.1016/j.jalz.2010.11.007
3. Doraiswamy, P. M., Sperling, R. A., Coleman, R. E., Johnson, K. A., Reiman, E. M., Davis, M. D., et al. (2012). Amyloid-szlig; assessed by florbetapir F18 PET and 18-month cognitive decline: a multicenter study. Neurology 79, 1636-1644. doi:10.1212/WNL.0b013e3182661f74
4. Erkinjuntti, T., and Rockwood, K. (2003). Vascular dementia. Semin. Clin. Neuropsychiatry 8, 37-45. doi:10.1053/scnp.2003.50004
5. Esteban-Santillan, C., Praditsuwan, R., Ueda, H., and Geldmacher, D. S. (1998). Clock drawing test in very mild Alzheimer's disease. J. Am. Geriatr. Soc. 4, 1266-1269.
6. Frederikse, P. H. (2000). Amyloid-like protein structure in mammalian ocular lenses. Curr. Eye Res. 20, 462-468. doi:10.1076/0271-3683(200006)2061-YFT462
7. Goldstein, L. E., Muffat, J. A., Cherny, R. A., Moir, R. D., Ericsson, M. H., Huang, X., et al. (2003). Cytosolic szlig;-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet 361, 1258-1265. doi:10.1016/S0140-6736(03)12981-9
8. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi:10.1126/science.1072994
9. Hintersteiner, M., Enz, A., Frey, P., Jaton, A. L., Kinzy, W., Kneuer, R., et al. (2005). In vivo detection of amyloid-b deposits by near-infra red imaging using an oxazine-derivative probe. Nat. Biotechnol. 23, 577-583. doi:10.1038/nbt1085
10. Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., et al. (2012). National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 8, 1-13. doi:10.1016/j.jalz.2011.10.007
11. Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128. doi:10.1016/S1474-4422(09)70299-6
12. Karran, E., Mercken, M., and De Strooper, B. (2011). The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nature 10, 698-712. doi:10.1038/nrd3505
13. Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., et al. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburg Compound-B. Ann. Neurol. 55, 306-319. doi:10.1002/ana.20009
14. Koberling, F., Krämer, B., Kapusta, P., Patting, M., Wahl, M., Erdmann, R., et al. (2007). "Time-resolved confocal fluorescence microscopy: novel technical features and applications for FLIM, FRET and FCS using a sophisticated data acquisition concept in TCSPC,"in Proceedings of SPIE, Vol. 6583, :65830Y.
15. Koronyo, Y., Salumbides, B. C., Black, K. L., and Koronyo-Hamaoui, M. (2012). Alzheimer's disease in the retina: imaging retinal Aszlig; plaques for early diagnosis and therapy assessment. Neurodegener. Dis. 10, 285-293. doi:10.1159/000335154
16. Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A. V., Miller, C. A., Ko, M. K., Black, K. L., et al. (2011). Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54, S204-S217. doi:10.1016/j.neuroimage.2010.06.020
17. Lakowicz, J. R. (2006). Principles of Fluorescence Spectroscopy, 3rd Edn. Springer.
18. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. doi:10.1212/WNL.34.7.939
19. McKhann, G., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R. Jr., Kawas, C. H., et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute of Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 263-269. doi:10.1016/j.jalz.2011.03.005
20. Michael, R., Rosandic, J., Montenegro, G. A., Lobato, E., Tresserra, F., Barraquer, R. I., et al. (2012). Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer's disease. Exp. Eye Res. 106, 5-13. doi:10.1016/j.exer.2012.10.012
21. Moncaster, J. A., Pineda, R., Moir, R. D., Lu, S., Burton, M. A., Ghosh, J. G., et al. (2010). Alzheimer's disease amyloid-szlig; links lens and brain pathology in Down syndrome. PLoS ONE 5:e10659. doi:10.1371/journal.pone.0010659
22. Nakada, T., Matsuzawa, H., Igarashi, H., Fujii, Y., and Kwee, I. L. (2008). In vivo visualization of senile-plaque-like-pathology in Alzheimer's disease patients by MR microscopy on a 7 T system. J. Neuroimaging 18, 125-129. doi:10.1111/j.1552-6569.2007.00179.x
23. Nordberg, A. (2004). PET imaging of amyloid in Alzheimer's disease. Lancet Neurol. 3, 519. doi:10.1016/S1474-4422(04)00853-1
24. Parnell, M., Guo, L., Abdi, M., and Cordeiro, M. F. (2012). Ocular manifestations of Alzheimer's disease in animal models. Int. J. Alzheimers Dis. 2012:786494. doi:10.1155/2012/786494
25. Reiman, E. M., Quiroz, Y. T., Fleisher, A. S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., et al. (2012). Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol. 11, 1048-1056. doi:10.1016/S1474-4422(12)70228-4
26. Sutharsan, J., Dakanali, M., Capule, C. C., Haidekker, M. A., Yang, J., and Theodorakis, E. A. (2010). Rational design of amyloid binding agents based on the molecular rotor motif. ChemMedChem 5, 56-60. doi:10.1002/cmdc.200900440
27. Yang, L., Rieves, D., and Ganley, C. (2012). Brain amyloid imaging - FDA approval of florbetapir F18 injection. N. Engl. J. Med. 367, 885-887. doi:10.1056/NEJMp1208061